Post-Acute Symptomatic Seizure Clinic – PASS Clinc October 13, 2025 The purpose of the study is to identify certain processes following brain injury that may be associated with the risk of developing epilepsy.
Long Term, Observational Registry of Patients with Generalized Myasthenia Gravis Who have Received Treatment with Complement C5 Inhibition Therapies October 10, 2025 Brief Summary Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®). Detailed Description At the time of enrollment in the Registry, participant records will...
Statins Use in Intracerebral Hemorrhage Patients (SATURN) October 10, 2025 This is a study being conducted at many sites across the US to evaluate patients who are older than 50 years old, who have sudden bleeding in the brain (intracerebral hemorrhage) while taking a statin medication. It is unclear if continuing to take a statin medication after this type of...
ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) October 10, 2025 The purpose of this study is to evaluate both sporadic (not inherited), and familial (inherited), forms of frontotemporal lobar degeneration (FTLD). Patients include both those who have symptoms of FTLD and those who do not (yet have a family history involving FTLD). This is an observational study, meaning that there...
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE) October 10, 2025 The ASPIRE trial aims to study anticoagulant medications in patients who have had an intracerebral hemorrhage (bleeding in the brain) who also have atrial fibrillation (irregular heartbeats). Participants who agree to study participation will receive either Aspirin or Apixaban and followed for 12-36 months to see if they have any...
Brain Oxygen Optimization in Severe Traumatic Brain Injury-Phase 3 (BOOST-3) October 10, 2025 A multicenter, randomized, blinded-endpoint, comparative effectiveness study of goal-directed critical care based upon monitoring of brain tissue oxygen and intracranial pressure versus monitoring of intracranial pressure alone in patients with severe traumatic brain injury. Overview Traumatic brain injury (TBI) is a major cause of death and disability in developed societies....
Dementia with Lewy Bodies Consortium (DLBC) October 10, 2025 This study aims to establish a research network and registry for persons with Dementia with Lewy Bodies (DLB) in order to characterize the disease and aid in future clinical trials.
UNC Neurologist Dr. Diana Cejas Honored with 2025 AMWA Inspire Award October 10, 2025 The Department of Neurology at UNC Chapel Hill is proud to announce that Dr. Diana Cejas, Associate Professor of Neurology, has been selected as a recipient of the 2025 AMWA Inspire Award by the American Medical Women’s Association (AMWA). This prestigious award celebrates accomplished women in medicine who exemplify the...
UNC Neurology Announces Dr. Qian-Zhou (Jojo) Yang as New Division Chief for Child Neurology October 7, 2025 The Department of Neurology at the University of North Carolina School of Medicine is proud to announce the appointment of Dr. Qian-Zhou (Jojo) Yang, MD, Associate Professor of Neurology, as Division Chief for Child Neurology. Dr. Yang steps into this role with a strong foundation in child neurology and epilepsy...
Jill Watson, MHA, Named Associate Chair of Administration for the Department of Medicine October 2, 2025 Jill Watson, MHA, has been named Associate Chair of Administration for the Department of Medicine, effective November 3, 2025. The Department of Neurology celebrates her leadership and contributions as she transitions into this new role. The Department of Neurology congratulates Jill Watson, MHA, on her appointment as the next Associate...